Isaac Geldhart is a survivor of the Holocaust. He arrived in New York City as an orphan, reinvented himself as a bon vivant, married well, and found fame and fortune as a champion of authors who are passionate about their work rather than its best-seller potential. He faces a family-business conflict, the potential Japanese takeover of his increasingly insolvent firm. He must browbeat his three children, all principal stockholders whom he dismisses in varying degrees, into accepting his plan to publish a six-volume scholarly work on Nazi medical experiments, despite their belief that a highly successful commercial novel is the only thing that will keep them from going under.
The play transferred to the Lincoln Center's Newhouse Theater on January 31, 1992.[4] The play closed on July 26, 1992 after 205 performances.[5]
Rifkin won the Drama Desk Award for Outstanding Actor in a Play.[6] The play won the 1992 Lucille Lortel Awards, Outstanding Director, Daniel Sullivan and Outstanding Actor, Ron Rifkin.[5]
The film was released by Miramax in the United States in 1996, after being shown at several film festivals, including the Deauville Festival du Film Americain (August–September 1996), Boston Film Festival (September 1996), and Mill Valley Film Festival (October 1996).[13] Sullivan was nominated for the Grand Special Prize at the Deauville Film Festival.[14]